(2-Fluoro-5-methoxypyridin-3-yl)methanol, 96%, 250mg

tert-Butyl 4-((2-bromo-4-fluorophenyl)amino)-4-cyanopiperidine-1-carboxylate, 98%, 250mg

3-Aminobenzoesäure, >=98 %, zur Synthese, 250 g, kunststoffverpackung.

D(+)-Saccharose, 1 kg

1,4-Bis(bromomethyl)-2,5-dimethylbenzene>98.0%(GC)1g

4,4,5,5-Tetramethyl-2-(4-trifluoromethylphenyl)-1,3,2-dioxaborolane, 95.0%, 1g

3-tert-Butyl-1-methyl-1H-pyrazole-5-carboxylic acid methyl ester, 95.0%, 5g

4-ethoxy-2-hydrazinyl-6-methylpyrimidine, 95.0%, 1g

1,1,1-Trifluoro-hexan-2-one, 90%, 25g

1-(4-Bromophenyl)-1H-imidazole-4-carboxylic acid, 250mg

1-(3-Ethynyl-2-fluorophenyl)ethan-1-one, 250mg

5-Bromo-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione, 97%, 250mg

1-(4-Chlorophenyl)-1-methylethylamine, 97.0%, 5g